FTXH ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
BMY	B	1.63	7.51
PFE	D	-0.21	7.39
ABBV	A	-0.07	7.31
JNJ	D	-0.51	7.17
MRK	F	-2.32	7.07
ZTS	C	-1.01	3.91
GILD	A	0.95	3.90
CAH	B	-0.11	3.59
AMGN	D	-0.18	3.56
VTRS	D	-0.17	3.52
UTHR	C	-1.50	3.51
BIIB	F	-1.08	3.50
LLY	D	0.75	3.37
REGN	D	-0.63	3.25
JAZZ	F	0.61	2.99
OGN	F	-1.33	2.96
CRL	F	-0.61	2.42
ELAN	D	-0.41	1.81
MEDP	F	1.03	1.72
NBIX	F	-0.18	1.26
HALO	D	2.68	1.22
ALKS	B	0.59	1.00
PRGO	F	-1.49	0.90
PBH	D	-1.19	0.82
EXEL	B	0.76	0.81
PTGX	C	1.37	0.74
ALNY	C	-1.63	0.67
CORT	B	-1.90	0.64
ACLX	C	-6.40	0.62
ADMA	C	-1.37	0.57
EXAS	C	-1.68	0.55
TWST	D	-0.28	0.55
KYMR	D	-3.37	0.52
TGTX	C	-1.97	0.52
ITCI	D	-0.04	0.51
INCY	B	-0.63	0.51
BPMC	F	0.84	0.50
INSM	D	0.19	0.49
VKTX	C	4.34	0.49
RNA	B	-2.87	0.49
VRTX	D	-1.62	0.48
MYGN	D	-0.26	0.48
AMRX	B	-1.58	0.48
ACAD	F	-1.11	0.48
SRPT	F	0.16	0.47
KRYS	D	-2.25	0.46
IONS	F	0.79	0.44
BMRN	F	-0.63	0.44
VCEL	F	1.62	0.43

Represented by ETF Holdings

Keywords: Biopharmaceutical Biotechnology Medicine S&P 500 Pharmaceutical Products Cancer Diabetes Life Sciences Infectious Diseases Pain Clinical Development Schizophrenia Animal Health Depressive Disorder Disease Hypertension Immunology Inflammation Nasdaq 100 Pharmaceutical

Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Distribution Drug Manufacturers - General

Recent News for First Trust Nasdaq Pharmaceuticals ETF & its Holdings

Date	Stock	Title
Oct 2	LLY	Jim Cramer Remains Steadfast On Eli Lilly and Company (NYSE:LLY)
Oct 2	NBIX	The Play On Neurocrine Biosciences
Oct 2	LLY	Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
Oct 2	JNJ	Johnson & Johnson's Options: A Look at What the Big Money is Thinking
Oct 2	EXEL	EXEL vs. CSLLY: Which Stock Is the Better Value Option?
Oct 2	LLY	Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Oct 2	BIIB	Investors in Biogen (NASDAQ:BIIB) have unfortunately lost 32% over the last three years
Oct 2	LLY	Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
Oct 2	JAZZ	Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
Oct 2	PFE	Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Oct 2	JNJ	Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Oct 2	GILD	Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
Oct 2	LLY	Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
Oct 2	LLY	Eli Lilly Building $4.5B Pharmaceutical Factory in Indiana
Oct 2	ABBV	AbbVie: $200 Peak (Rating Downgrade)
Oct 2	BMY	STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Oct 2	RNA	Avidity Biosciences: Intriguing Oligonucleotide Program To Monitor Over Longer Term
Oct 2	JNJ	J&J prostate cancer therapy outperforms in real-world study
Oct 2	HALO	High Growth Tech Stocks In The United States To Watch
Oct 2	ALNY	Here's Why You Should Add ALNY Stock to Your Portfolio Right Now

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Nasdaq 100

ETF Components for FTXH - First Trust Nasdaq Pharmaceuticals ETF